Action Duchenne International Conference 2018 Abstract – Phase 1b/2 study of the anti-myostatin adnectin RG6206

Action Duchenne International Conference 2018 Abstract
Nov 9th–11th, 2018, Birmingham, UK.
Submission deadline: August 31st, 2018


A Phase 1b/2 study of the anti-myostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy: A 72-week treatment update